home / stock / acst / acst short
Short Information | Acasti Pharma Inc. (NASDAQ:ACST)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 70,313 |
Total Actual Volume | 331,390 |
Short Trends | |
---|---|
Cover Days | 17 |
Short Days | 1 |
No Change Days | 2 |
Averages | |
---|---|
Average Short Volume | 3,516 |
Average Short Percentage | 21.81% |
Is there a ACST Short Squeeze or Breakout about to happen?
See the ACST Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
07-16-2024 | $3.03 | $3.04 | $3.15 | $3.0101 | 8,569 | 273 | 3.19% |
07-15-2024 | $3.12 | $3.03 | $3.16 | $3.01 | 17,551 | 2,864 | 16.32% |
07-12-2024 | $2.98 | $3.12 | $3.17 | $2.98 | 7,531 | 2,351 | 31.22% |
07-11-2024 | $3.1 | $3.03 | $3.1 | $3.02 | 12,573 | 926 | 7.36% |
07-10-2024 | $3.01 | $3.07 | $3.19 | $2.9757 | 21,849 | 11,197 | 51.25% |
07-09-2024 | $2.77 | $3.06 | $3.07 | $2.77 | 14,881 | 3,089 | 20.76% |
07-08-2024 | $2.85 | $2.85 | $2.95 | $2.77 | 11,487 | 928 | 8.08% |
07-05-2024 | $2.842 | $2.8896 | $2.8896 | $2.79 | 2,430 | 465 | 19.14% |
07-03-2024 | $2.82 | $2.9 | $3.07 | $2.82 | 14,122 | 1,197 | 8.48% |
07-02-2024 | $2.87 | $2.85 | $3.05 | $2.81 | 6,681 | 3,261 | 48.81% |
07-01-2024 | $2.89 | $2.92 | $2.92 | $2.81 | 8,245 | 2,743 | 33.27% |
06-28-2024 | $2.97 | $2.92 | $3.055 | $2.22 | 86,403 | 11,698 | 13.54% |
06-27-2024 | $2.93 | $2.97 | $3.03 | $2.85 | 8,496 | 2,175 | 25.6% |
06-26-2024 | $3.08 | $2.96 | $3.08 | $2.92 | 7,589 | 701 | 9.24% |
06-25-2024 | $3.1144 | $3.1 | $3.2 | $3.1 | 13,831 | 533 | 3.85% |
06-24-2024 | $3.24 | $3.2 | $3.24 | $3.1411 | 7,509 | 1,074 | 14.3% |
06-21-2024 | $3.15 | $3.3 | $3.3 | $3.09 | 26,065 | 8,612 | 33.04% |
06-20-2024 | $3.29 | $3.15 | $3.3 | $3.06 | 18,593 | 3,794 | 20.41% |
06-18-2024 | $3.26 | $3.2922 | $3.32 | $3.2 | 19,316 | 4,344 | 22.49% |
06-17-2024 | $3.25 | $3.26 | $3.29 | $3.2 | 17,669 | 8,088 | 45.78% |
News, Short Squeeze, Breakout and More Instantly...
PRINCETON, N.J., June 27, 2024 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (Nasdaq: ACST) (Acasti or the Company), a late-stage, biopharma company advancing GTX-104, its novel injectable formulation of nimodipine that addresses high unmet medical needs for a rare disease, aneurysmal subarachnoid hemor...
Patient Enrollment in Pivotal STRIVE-ON Phase 3 Safety Trial for GTX-104 On-Track for Potential NDA Submission in 1H Calendar 2025 Projected Cash Runway into Second Calendar Quarter 2026 PRINCETON, N.J., June 21, 2024 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (Nasdaq: ACST) (...